Helius Medical Technologies ROE 2014-2024 | HSDT
Current and historical return on equity (ROE) values for Helius Medical Technologies (HSDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Helius Medical Technologies ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.01B | $0.00B | -400.00% |
| 2024-09-30 | $-0.01B | $0.00B | -285.71% |
| 2024-06-30 | $-0.01B | $0.01B | -307.69% |
| 2024-03-31 | $-0.01B | $0.00B | -333.33% |
| 2023-12-31 | $-0.01B | $0.00B | -225.00% |
| 2023-09-30 | $-0.01B | $0.00B | -236.36% |
| 2023-06-30 | $-0.01B | $0.01B | -125.00% |
| 2023-03-31 | $-0.01B | $0.01B | -150.00% |
| 2022-12-31 | $-0.01B | $0.01B | -169.70% |
| 2022-09-30 | $-0.01B | $0.01B | -144.44% |
| 2022-06-30 | $-0.02B | $0.01B | -242.86% |
| 2022-03-31 | $-0.02B | $0.01B | -245.16% |
| 2021-12-31 | $-0.02B | $0.01B | -200.00% |
| 2021-09-30 | $-0.02B | $0.01B | -234.48% |
| 2021-06-30 | $-0.02B | $0.01B | -222.22% |
| 2021-03-31 | $-0.01B | $0.01B | -192.00% |
| 2020-12-31 | $-0.01B | $0.00B | -311.11% |
| 2020-09-30 | $-0.02B | $0.00B | -320.00% |
| 2020-06-30 | $-0.02B | $0.01B | -292.31% |
| 2020-03-31 | $-0.02B | $0.01B | -193.94% |
| 2019-12-31 | $-0.01B | $0.01B | -100.00% |
| 2019-09-30 | $-0.01B | $0.01B | -90.91% |
| 2019-06-30 | $-0.01B | $0.01B | -116.13% |
| 2019-03-31 | $-0.03B | $0.01B | -1800.00% |
| 2018-12-31 | $-0.03B | $0.01B | 1450.00% |
| 2018-09-30 | $-0.03B | $0.00B | 448.00% |
| 2018-06-30 | $-0.04B | $-0.01B | 464.52% |
| 2018-03-31 | $-0.02B | $0.00B | 505.26% |
| 2017-12-31 | $-0.03B | $-0.01B | 644.44% |
| 2017-09-30 | $-0.03B | $-0.01B | 771.43% |
| 2017-06-30 | $-0.02B | $0.00B | 3400.00% |
| 2017-03-31 | $-0.01B | $0.00B | -1866.67% |
| 2016-12-31 | $-0.01B | $0.00B | -1200.00% |
| 2016-09-30 | $-0.01B | $0.00B | -960.00% |
| 2016-06-30 | $-0.01B | $0.01B | -1400.00% |
| 2016-03-31 | $-0.01B | $0.00B | 560.00% |
| 2015-12-31 | $-0.01B | $0.00B | 285.71% |
| 2015-09-30 | $-0.01B | $0.00B | 400.00% |
| 2015-06-30 | $-0.01B | $0.00B | 1100.00% |
| 2015-03-31 | $-0.01B | $0.00B | 2000.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.002B | $0.001B |
| Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania. | |||